Caribou Biosciences
Caribou Biosciences is a clinical-stage biopharmaceutical company focused on developing transformative genome‑edited allogeneic cell therapies. Leveraging its proprietary CRISPR hybrid RNA‑DNA (chRDNA) technology, Caribou creates off‑the‑shelf CAR‑T cell therapies aimed at treating devastating diseases such as cancers and genetic disorders. The company emphasizes precision genome editing, armored cell therapies, and rapid patient access, positioning itself as a leader in the CRISPR field.
Caribou Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Genome Editing, Cell Therapy, and CRISPR.
Caribou Biosciences’ developer surface includes documentation and 7 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Build 2
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API
Other 1
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.